• Status Current Investment
  • Location Billerica, MA
  • Industry Industrial and Life Sciences Technology
  • Investment Date May 2021


Pion is a leading provider of analytical instrumentation for formulation development and quality control in the life sciences industry.

Value proposition

Helps pharmaceutical scientists to make efficient, early phase screening of drug compounds and provide critical data for the development of drugs. 


Leading biopharmaceutical, academic, and research institutions around the globe. Its products are used in labs focused on drug screening and development of formulations across small molecule drugs, large molecule biologics, vaccines, and other therapeutics.

Related News
Dec 22 2022
Pion Acquires BEE International
Dec 12 2022
Pion Inc acquires Two Square Science adding new capabilities to an innovative portfolio for drug development
Sep 29 2022
Pion Showcases How to Achieve In-Vivo Level Insights Via In-Vitro Solutions at AAPS PharmSci 360 2022
Jun 29 2022
Pion’s commercial offering goes global with two key appointments
Mar 25 2022
Pion Boosts Service Offering, Bringing Excellent Customer Experiences to the Fore
Nov 16 2021
Pion Inc Unveils New Model of its Industry-First Subcutaneous Injection Site Simulator Investigate Drug Release Performance of Subcutaneous Formulations In Vitro, With New SCISSOR N3
May 20 2021
SFW Capital Partners Completes A Strategic Recapitalization of Pion Inc., a Leading Instrumentation Provider for Life Sciences